A retrospective study to clarify the efficacy and adverse events of lenvatinib for advanced HCC refractory to transcatheter chemoembolization in clinical practice
Latest Information Update: 20 Dec 2019
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 20 Dec 2019 New trial record